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Phosphorylation of GAP-43 and the Effect on APP Processing

Kaitlynn Tracy and Eric M. Norstrom*
Department of Biological Sciences

ABSTRACT
The phosphorylation of Growth Associated Protein may affect the occurance of
interaction between GAP-43 and the Amyloid Precursor Protein. By synthesizing mutants of the GAP-43
protein, the amount of C-terminal fragments of APP that results from the interaction could be observed
under various conditions. An alanine mutant (S41A) and an aspartate mutant (S41D) and the wild type
GAP-43 were all co-expressed with APP in moues neuroblastoma cells and analyzed on a Western blot.
The mutant used to block phosphorylation, S41A, showed a greater occurance of interaction with APP
while the mutant that was created to mimic the effect of phosphorylation, S41D, showed less interaction.
Further study of this research would include verifying the interaction of the two proteins through a coimmunoprecipitation experiment and determining the mechanism by which GAP-43 mediates changes in
APP metabolism.

INTRODUCTION
Alzheimer’s Disease (AD) is the sixth leading
causes of death in the United States and the most
common form of dementia, causing problems with
memory, cognition, and behavior (5). The disease is
characterized by a buildup of amyloid plaques in
the brain, which is associated with a decrease in
efficiency of neuronal communications (6). There is
no cure or effective treatment for the disease
(Figure 1). The plaques that damage the brain’s
tissues are formed by fibrils of a metabolite of a
____________________________________
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Located on the membrane of cells, the neuronal
form of APP is a 695 amino acid protein that can
be cleaved in several locations by complex
metabolic processing (7). If the protein is
cleaved at the α-site by the enzyme α –secretase,
then a second cleavage by γ –secretase yields a
soluble protein that is non-pathogenic to the
cells around it (Figure 2). However, if the
protein is cleaved first at the β site by βsecretase, then subsequent cleavage by γ –
secretase releases β-amyloid (Aβ) peptides,
which have a propensity to aggregate and form
fibrils and plaques, leading to pathologies
related to AD (7;9). Thus, it is of significant
interest to identify and explore proteins that may
bind to and influence the processing of APP (2).

protein called Amyloid Precursor Protein (APP).
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Growth Associated Protein (GAP
(GAP-43) is a
cytosolic protein involved in cell growth, neuronal
axon extension, and molecular mechanisms of
learning and memory (3). Recently, our lab has
found that GAP-43
43 can interact with APP and alter
its rate of metabolism, an effect that suggests
dependence on membrane localization (1;3). One
factor that affects
ffects the functioning of GAP
GAP-43 is
phosphorylation on a serine residue, wh
which has a
regulatory effect on GAP-43
43 membrane
localization (4;8). Thus, since APP is a
transmembrane protein, I hypothesize that
phosphorylation of GAP-43
43 may be a critical
factor in its modulatory effect on APP metabolism.

OBJECTIVES
The purpose of this research is to determine
whether GAP-43 phosphorylation
orylation plays a role in
modulation of APP processing. This is tested by
producing phosphorylation deficient and
mimetic mutants of GAP-43
43 and co-expressing
co
them with APP in cultured cells. Following that,
an assay will be used to measure the impact
i
of
the Wild-type, phospho-deficient,
deficient, and phosphophospho
mimetic GAP-43
43 on the APP metabolic
processing by comparing the amount of CC
terminal fragments that result for each given
sample. A reduction of C-terminal
terminal fragments
would indicate a greater interaction between
APP and GAP-43.

METHODS

Figure 1. As Alzheimer’s develops from early to late
stages, a buildup of plaques composed of Aβ are visible
in greater density throughout the brain. (Figure source:
Alzheimer’s Association)

Figure 2. Aβ is formed from the proteolytic processing
of the amyloid precursor protein (APP). APP has
multiple metabolic fates, only one of which leads to
the formation of Aβ. (Figure adapted from O’Brien and
Wong, 2011)
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To test the effect of phosphorylation on the GAPGAP
43 protein, molecular and cell culture techniques
were used to co-express
express APP with a GAP-43
GAP
that
carries a mutation rendering it unable to be
phosphorylated. The metabolism of APP in this
condition will be compared
ompared to samples in which
APP has been co-expressed
expressed with a wild type form
of GAP-43. As an additional condition, a form of
GAP-43
43 that has been mutated to mimic the
phosphorylated state will also be tested.
To begin the experiment, site-directed
directed mutagenesis
mutage
was enacted to change the phosphorylation site of
GAP-43.
43. Mutagenesis is a laboratory technique
that changes the genetic information on a strand of
DNA in order to alter the makeup and functions of
the protein that is expressed
sed from the DNA code
(Figure 3). For this experiment the DNA was
mutated to alter a serine residue at amino acid 41
(the consensus phosphorylation site of GAP-43)
GAP
to
an alanine, which does not possess the required
hydroxyl group onto which the phosphate is added
via an enzyme-mediated
ated dehydration reaction, thus
preventing the mutant protein from being
phosphorylated. In parallel reactions, the same
codon was changed to aspartate that has a similar
charge and structural profile to that of phosphate
and can act as a phospho-mimetic
mimetic (D).
(
Once
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cloning of the mutants was completed, the GAP
GAP43 mutant and the wild type GAP-43
43 protein
proteins were
then co-expressed
expressed with APP in cultured mouse
neuroblastoma (N2a) cells and the metabolites of
APP were measured by Western blot analysis.
This
proceduree
is
conducted
through
polyacrylamide gel electrophoresis (SDS
(SDS-PAGE),
which separates the proteins by their relative size,
allowing for the identification of the cleaved APP
products by their lengths.
After the
electrophoresis, the proteins were transferr
transferred to a
nitrocellulose membrane and incubated with
antibodies that bind to APP. Then, using
chemiluminescence, the antibodies that were
attached to the APP metabolites were detected and
quantified, and compared.

Figure 3.. Polymerase Chain Reaction (PCR) was used
to amplify specific DNA sequences of the GAP
GAP-43
open reading frame.

RESULTS
The first step of the procedure was to amplify
the specific DNA sequences of the GAP
GAP-43 open
reading frame (ORF).. Primers included codons
to mutate S41 to either alanine (S41A) or
aspartate (S41D).. Gels were run and imaged to
confirm that each mutant contained both the
forward and reverse primers from the first round
of PCR, and the full ORF transcript in the
second round of the reaction. The images from
the gel are shown for the alanine mutant belo
below
(Figure 4)(Figure 5).
).
Each fra
fragment was
confirmed based on itss length in base pairs.
Then, each sample was digested to run on a gel
in order to confirm the presence of the inserts in
each sample. As shown below, the first, th
third,
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and fourth samples from each mutant contained
the templates and were suitable for the
subsequent procedures (Figure 6).
6
From there, the samples were sent to a
laboratory to have their sequences confirmed.
Chromatograms were returned for each sample,
showing the specific nucleotide bases in each
piece of DNA. For the wild type GAP-43,
GAP
the
codon at the forty-first
first residue is AGC codes for
a serine amino acid. However, in the first sample
the codon is GAC. This confirmed the aspartate
codon in the first sample (Figure 8).
8 Similarly
the codon in the second sample was GCC, which
wh
codes for alanine (Figure 7).
With the sequences confirmed, the wild type and
mutants were co-expressed
expressed with APP in cultured
mouse neuroblastoma (N2a), and the metabolites
were measures
sures with a Western Blot analysis.
Additionally, the presence of GAP-43
GAP
was
confirmed in the Western Blot procedure to
ensure that all samples contained the protein.
The chemiluminescence image is shown below
(Figure 9). The Western Blot shows that there
was a greater reduction of C-terminal
terminal fragments
when the APP was co-expressed
expressed with S41A than
when it was co-expressed
expressed with the GAP-43
GAP
wild
type. The S41A mutant was unable to be
phosphorylated, which resulted in a reduction of
C-terminal fragments than the wild type GAP-43
protein. This would suggest
est that there was an
increase in interaction between the mutated
protein and APP than with the wild type GAPGAP
43.
Attempting to mimic the effects of
phosphorylation in the S41D mutant did not
result in the same amount
unt of functional
interaction as wild type GAP-43,
GAP
as shown by
the increase of C-terminal
terminal fragments of APP on
the Western Blot. These speculatie data readings
suggest that GAP-43
43 associates with APP
primarily in its non-phosphorylated
phosphorylated form.
Phosphorylation at serine 41 may thus serve as a
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regulatory modification that inhibits
APP/GAP-43 complex formation.

the

Further study of the topic would include a
replication of the preliminary results. A
quantitative determination of the relative
population
of
phosphorylated
and
unphosphorylated GAP-43
43 would be calculated,
and a co-immunoprecipitation
noprecipitation of APP with wild
wildtype and mutant GAP-43
43 would be conducted.

Figure 6.. Screening of S41A and S41D clones.

Figure 4.. PCR Round 1, Generating S41A mutant
containing DNA

Figure 7.. The chromatogram indicates that the
codon for serine (AGC), was replaced with GCC
which codes for an alanine.

Figure 5.. PCR Round 2, Combining round 1 products
as a template to generate full ORF transcript.

https://via.library.depaul.edu/depaul-disc/vol4/iss1/14
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EXPERIMENTAL DESIGN

Figure 8.. The chromatogram indicates that the
codon for serine (AGC), was replaced with GAC
which codes for an aspartate.

Generation
of
Mutant
GAP-43:
GAP
Crossover PCR mutatgenesis was performed to
generate GAP-43 mutants from wild-type
wild
GAP43. Template DNA for the reactions was the
plasmid pAG3 containing the ORF of GAP-43.
GAP
Primers containing mutations at codons
indicated in poster were used for the
amplification reactions in the first round, the
products of which were used as the template for
the second cross-over
over round using flanking
primers. Products of round 2 were digested and
ligated into pAG3 vector, transformed into
DH5α cells and incubated over night (o/n) at
37°C on LB-agar plates containing the selective
antibiotic ampicilin.. Isolated colonies were
selected grown in 3mL LB Broth, with 50µg/mL
ampicilin att 37°C on a shaker at 250rpm
overnight.. Plasmids were isolated using alkali
lysis followed by matrix capture using the
GeneJET Plasmid Miniprep Kit (Fermentas).
(Ferm
Plasmid DNA was digested with the enzyme
BamHI and HinDIII to detect the presence of an
insert. Positive colonies were submitted for
sequencing at the University of Chicago
sequencing facility.
Cell culture:: N2a mouse neuroblastoma
cells were grown in DMEM with 10% FBS and
1% penicillin/streptomycin and incubated at
37°C under 5% CO2. Cells were passaged 1:10
every 3-4days.

Figure 9.. The Western Blot shows that there was a
greater reduction of C-terminal
terminal fragments when the
APP was co-expressed
expressed with S41A than when it was
co-expressed with the GAP-43
43 wild type. The
presence of GAP-43
43 was confirmed in the bottom
bands. The band inbetween
en APP CTF and APP
APP-Full
length present in the mutants was determined to be
background and noise and excluded from futher
experimentation.

Transfection:: N2a cells were transiently
cotransfected with APP and either GAP-43,
GAP
GAP-43 S41A, or GAP-43
43 S41D or GFP as a
control
ontrol protein. Transfection was performed in
30mm culture plates at a cell confluence of
approximately 80% using Lipofectamine 2000
(Invitrogen). Coexpression was allowed for
40hrs at 37°C under 5% CO2.
Cell lysis: Cells were lysed on ice using
200uL lysiss buffer (50mM Tris pH 7.4, 150mM
NaCl, 1mM EDTA, 0.5% IGEPAL, 0.5%
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Na:DOC and a protease inhibitor cocktail).
Insoluble
material
was
removed
by
centrifugation at 16,000 x g and the resultant
supernatants were transferred into new
microcentrifuge tubes and the pellets discarded.
The lysis contents were analyzed for protein
concentration using the BCA method (Pierce).
Western blot: Lysates samples were
boiled in Laemmli sample buffer and analyzed
by Western blot after poly-acrylamide gel
electrophoresis, on hand-poured gradient
tris/tricine gels. Proteins were transferred onto
polyvinylide fluoride membranes (Bio-Rad) and
washed 3 times with phosphate buffered saline
containing 0.1% tween-20 detergent (PBST) for

5 min each and then blocked with 5% milk in
PBST for 1hr at room temperature with rocking.
The membranes were then transferred to
containers containing the appropriate primary
antibody and incubated on a rocker at 4°C o/n
and then washed 3x for 5 min each with PBST
and incubated with the appropriate secondary
antibody with rocking for 1hr at room
temperature. The membranes were then washed
4 times for 5 minutes each with PBST and rinsed
with distilled water. Immunoreactivity was
visualized using SuperSignal West Pico
Chemiluminescent Substrate (Thermo Scientific)
and read using FluorChem HD2 software or
OmegaLum
G
CCD
imager.
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